Xu Stella
Insider CIK 1728741 · TPST Director · NXTC Director · ARMO Director · DSGN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics, Inc. | A Award deriv | 2023-05-31 | 2023-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | S Sale | 2022-03-22 | 2022-03-22 | 1,455 | $18.63 | $27.1K | 4,129,950 | SEC↗ |
| DSGN Design Therapeutics, Inc. | S Sale | 2022-03-21 | 2022-03-22 | 24,000 | $19.01 | $456.2K | 4,131,405 | SEC↗ |
| DSGN Design Therapeutics, Inc. | S Sale | 2022-03-18 | 2022-03-22 | 552,225 | $19.04 | $10.51M | 4,168,605 | SEC↗ |
| DSGN Design Therapeutics, Inc. | S Sale | 2022-03-18 | 2022-03-22 | 13,200 | $20.34 | $268.5K | 4,155,405 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | A Award deriv | 2021-07-01 | 2021-07-06 | 6,635 | — | $0 | 6,635 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | A Award deriv | 2021-07-01 | 2021-09-20 | 6,635 | — | $0 | 6,635 | SEC↗ |
| TPST Millendo Therapeutics, Inc | A Award | 2021-06-25 | 2021-06-29 | 579,710 | — | $0 | 579,710 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 14,250 | — | $0 | 14,250 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 7,236,938 | — | $0 | 0 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 458,016 | — | $0 | 0 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 280,991 | — | $0 | 4,720,830 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2021-03-30 | 2021-04-01 | 10,000 | $20.00 | $200.0K | 4,730,830 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 4,439,839 | — | $0 | 4,439,839 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2021-03-25 | 2021-03-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 14,250 | — | $0 | 14,250 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 7,861,636 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-05-13 | 2019-05-13 | 125,000 | $15.00 | $1.88M | 1,103,570 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 978,570 | — | $0 | 978,570 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | U Tender | 2018-06-22 | 2018-06-22 | 404,900 | $50.00 | $20.25M | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 404,900 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 404,900 | — | $0 | 404,900 | SEC↗ |